GASTRIC NEUROENDOCRINE CARCINOMA
Clinical trials for GASTRIC NEUROENDOCRINE CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new GASTRIC NEUROENDOCRINE CARCINOMA trials appear
Sign up with your email to follow new studies for GASTRIC NEUROENDOCRINE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New chemo combo fails to beat standard treatment for rare gut cancer
Disease control OngoingThis study tested whether a combination of temozolomide and capecitabine works better than the standard cisplatin and etoposide for people with advanced neuroendocrine cancer of the gut or pancreas that cannot be surgically removed. The trial enrolled 67 participants and was stop…
Matched conditions: GASTRIC NEUROENDOCRINE CARCINOMA
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated May 26, 2026 08:54 UTC
-
Immunotherapy duo takes on rare tumors in nationwide trial
Disease control OngoingThis study tests two immunotherapy drugs, nivolumab and ipilimumab, in adults with over 50 types of rare cancers. The goal is to see if this drug combination can shrink tumors or stop them from growing. The trial is no longer enrolling new participants, but results will help guid…
Matched conditions: GASTRIC NEUROENDOCRINE CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 08:28 UTC